As industrial corporations become more involved in developing new biological techniques, where does this leave the scientist? How will university biology departments maintain their integrity and autonomy? How will individual scientists react to growing corporate demands? These and other questions were explored when Nature brought together Sheldon Krimsky, Acting Director of the Program in Urban, Social and Environmental Policy at Tufts University, and David Baltimore, Professor of Biology at MIT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
The ties that bind or benefit. Nature 283, 130–131 (1980). https://doi.org/10.1038/283130a0
Issue Date:
DOI: https://doi.org/10.1038/283130a0
This article is cited by
-
Finding improved medicines: the role of academic–industrial collaboration
Nature Reviews Drug Discovery (2005)
-
Financial interests of authors in scientific journals: A pilot study of 14 publications
Science and Engineering Ethics (1996)